CD247 and plasma cell myeloma: Incorporating DAP10 or DAP12 into CAR constructs may therefore enhance NK cell activation more physiologically than CD3ζ alone, potentially improving anti-myeloma efficacy and persistence while maintaining NK-specific functional programs [28].